PLX (PLX) Stock Price & Analysis
PLX (PLX) rose 1.91% to USD 2.67 as of September 8, 2026 at 09:03 UTC, according to Nexqual real-time market data.
PLX last closed at USD 2.67; the session ranged USD 2.62–2.68 on volume of 859,696 shares. Market capitalization is —, with a 52-week range of USD 1.59–3.19 (ASE). Source: Nexqual, September 8, 2026 at 09:03 UTC.
Key Statistics (as of September 8, 2026 at 09:03 UTC)
| Price | USD 2.67 |
|---|---|
| Change | ▲ 1.91% (up) |
| Previous Close | USD 2.67 |
| Open | USD 2.67 |
| Day Range | USD 2.62 – 2.68 |
| 52-Week Range | USD 1.59 – 3.19 |
| Volume | 859,696 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (PLX)
Nexqual's technical model rates PLX "BUY" based on 5 bullish and 1 bearish signals across 128 daily candles, as of September 8, 2026 at 09:03 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 65.6 (neutral) |
| vs SMA50 | Above (USD 2.4) |
| MACD | 0.07 (positive) |
From PLX's Latest SEC 10-K Filing (filed 2026-03-18)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BLRX | BioLineRx Ltd. | USD 2.67 | ▼ 2.55% |
| PULM | Pulmatrix, Inc. | USD 1.39 | ▼ 5.44% |
| CANF | Can-Fite Biopharma Ltd | USD 2.23 | ▼ 5.51% |
| VSTM | Verastem, Inc. | USD 8.2 | ▲ 2.24% |
| RDHL | Redhill Biopharma Ltd. | USD 0.72 | ▼ 2.24% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:03 UTC. This page is informational and not investment advice.